Apical Flap Repositioning vs. Mucosa Excision With Free Gingival Grafts for Peri-Implant Keratinized Mucosa Augmentation (FGGIF)
Multicenter Randomized Clinical Trial Comparing Apical Flap Repositioning Versus Vestibular Mucosa Excision Associated With Free Gingival Grafts for Peri-Implant Keratinized Mucosa Augmentation
The goal of this clinical trial is to learn which surgical technique works better to increase the amount of firm gum tissue (called keratinized mucosa) around dental implants in adults.
The main question it aims to answer is:
-Does repositioning the gum flap upward with stitches lead to a greater gain in firm gum tissue width at 6 months compared to simply removing the extra gum tissue, when both techniques are combined with a free gum graft?
Researchers will compare two techniques used during the second stage of implant surgery to see which one produces a greater gain in firm gum tissue around the implant.
Participants will:
- Receive a free gum graft (a small piece of tissue taken from the roof of the mouth) placed around their dental implant during a routine surgical visit
- Be randomly assigned to one of the two surgical techniques
- Have digital scans of their mouth taken at 5 timepoints over 6 months
- Complete a pain diary and answer questions about their experience during the first week after surgery
- Attend follow-up visits at 6 weeks, 3 months, and 6 months after surgery
A tanulmány áttekintése
Állapot
Részletes leírás
This superiority multicenter randomized clinical trial is coordinated by the Universitat de Barcelona (UB) and includes the Universidad Complutense de Madrid (UCM) as a collaborating center.
Participant selection Adults with osseointegrated implants in the posterior maxilla or mandible presenting keratinized mucosa width of 2 mm or less and/or vestibular depth less than 4 mm will be screened for eligibility. Participants must be in periodontal and peri-implant health and have a plaque index of 15% or less.
Randomization Eligible participants will be randomly assigned (1:1) to one of two treatment groups using an Interactive Web Response System (IWRS) provided by Sealed Envelope Ltd. Randomization will take place intraoperatively, once the partial-thickness mucosal flap has been prepared.
Interventions
Group 1 (Control): Free gingival graft with apical repositioning and suturing of the vestibular mucosal flap to the periosteum Group 2 (Experimental): Free gingival graft with excision of the vestibular mucous tissue
Outcome assessment Soft tissue changes will be assessed at 5 timepoints (T0, Tim, T6w, T3m, T6m) using intraoral scans (TRIOS 3®, 3Shape) analyzed with Geomagic Control X® software through three-dimensional digital superimposition. Clinical measurements will also be performed using a calibrated periodontal probe and a customized thermoplastic stent to standardize the measurement point across visits.
Participants will complete a pain diary during the first 7 postoperative days recording pain intensity (100 mm visual analogue scale), analgesic consumption, and days with limited activity.
Sample size A total of 46 participants (23 per group) are required, accounting for a minimum clinically relevant difference of 1 mm in KTW gain, a standard deviation of 1.3 mm, 80% statistical power, 5% significance level, an intraclass correlation coefficient of 0.30 for multiple implants per patient, and a 15% dropout rate.
Statistical analysis The primary outcome will be analyzed in the intention-to-treat population using a generalized linear mixed model (GLMM), with patient as a random effect, adjusted for baseline KTW and study center.
Tanulmány típusa
Beiratkozás (Becsült)
Fázis
- Nem alkalmazható
Kapcsolatok és helyek
Tanulmányi kapcsolat
- Név: Octavi Camps-Font, DDS MS PhD
- Telefonszám: +34 934 024 269
- E-mail: ocamps@ub.edu
Tanulmányozza a kapcsolattartók biztonsági mentését
- Név: Prof. Dr.
- E-mail: ocamps@ub.edu
Tanulmányi helyek
-
-
Barcelona
-
Barcelona, Barcelona, Spanyolország, 08907
- Hospital Odontològic Universitat de Barcelona, L'Hospitalet de Llobregat,
-
Kapcsolatba lépni:
- Octavi Camps Font DDS MS PhD
- Telefonszám: +34 934 024 269
- E-mail: ocamps@ub.edu
-
-
Részvételi kritériumok
Jogosultsági kritériumok
Tanulmányozható életkorok
- Felnőtt
- Idősebb felnőtt
Egészséges önkénteseket fogad
Leírás
Inclusion Criteria:
- Men or women aged 18 years or older who voluntarily agree to sign the informed consent form before any study-related procedure is performed.
- Single or multiple edentulous spaces (≤3 units) located in the posterior maxilla or mandible, presenting osseointegrated implants in first-stage surgery with a -healing period of more than 8 weeks.
- ASA classification I or II.
- Periodontal and peri-implant health.
- O'Leary plaque index ≤15%.
- Keratinized mucosa width ≤2 mm and/or vestibular depth <4 mm at at least one site.
- Commitment to attend all follow-up visits over 6 months.
Exclusion Criteria:
- Systemic diseases that may interfere with performing FGG (free gingival graft), including but not limited to: poorly controlled diabetes mellitus (HbA1c > 8% or per clinical judgment), immunodeficiencies or immunosuppressive treatment, uncontrolled hematological diseases or coagulation disorders, anticoagulant or antiplatelet treatment that cannot be adjusted according to standard clinical practice, active neoplasms under treatment, severe renal or hepatic insufficiency, decompensated cardiovascular diseases, and any other medical condition that, in the investigator's judgment, could compromise participant safety or proper tissue healing.
- Any contraindication to oral surgical procedures.
- Periodontal and peri-implant health as defined by the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions.
- Patients who smoke tobacco or equivalent products, as well as former smokers with an abstinence period ≤12 months.
- History of substance abuse (drugs or alcohol) or any other factor (e.g., severe psychiatric illness) that, in the investigator's opinion, could interfere with the patient's ability to cooperate and comply with the study.
- Patients who have participated in a clinical trial within the last 30 days.
- Pregnant or breastfeeding women.
Tanulási terv
Hogyan készül a tanulmány?
Tervezési részletek
- Elsődleges cél: Kezelés
- Kiosztás: Véletlenszerűsített
- Beavatkozó modell: Párhuzamos hozzárendelés
- Maszkolás: Egyetlen
Fegyverek és beavatkozások
Résztvevő csoport / kar |
Beavatkozás / kezelés |
|---|---|
|
Aktív összehasonlító: Apical Flap Repositioning
Free gingival graft with apical repositioning and suturing of the vestibular mucosal flap to the periosteum during second-stage implant surgery.
|
Autologous free gingival graft harvested from the palate and placed at the recipient site.
The vestibular mucosal flap is repositioned apically and sutured to the periosteum during second-stage implant surgery.
|
|
Kísérleti: Vestibular Mucosa Excision
Free gingival graft with excision of the vestibular mucous tissue during second-stage implant surgery.
|
Autologous free gingival graft harvested from the palate and placed at the recipient site.
The vestibular mucous tissue is excised during second-stage implant surgery.
|
Mit mér a tanulmány?
Elsődleges eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Peri-implant keratinized tissue width (KTW) gain
Időkeret: Baseline (T0) to 6 months (T6m)
|
Absolute change in KTW, measured digitally as the linear distance between the mucosal margin and the mucogingival junction on the vestibular aspect of the implant, using Geomagic Control X® software on intraoral scan models (TRIOS 3®, 3Shape).
|
Baseline (T0) to 6 months (T6m)
|
Másodlagos eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Clinical gain in peri-implant keratinized tissue width (KTW)
Időkeret: Baseline (T0) to 6 months (T6m)
|
Absolute change in KTW, measured clinically with a calibrated periodontal probe using a customized thermoplastic stent.
|
Baseline (T0) to 6 months (T6m)
|
|
Change in graft height
Időkeret: Immediate postoperative (Tim), 6 weeks (T6w), 3 months (T3m), 6 months (T6m)
|
Change in graft height, measured in millimeters (mm), between immediate postoperative and 6 months, assessed by 3D digital superimposition.
|
Immediate postoperative (Tim), 6 weeks (T6w), 3 months (T3m), 6 months (T6m)
|
|
Change in graft width
Időkeret: Immediate postoperative (Tim), 6 weeks (T6w), 3 months (T3m), 6 months (T6m)
|
Change in graft width, measured in millimeters (mm), between immediate postoperative and 6 months, assessed by 3D digital superimposition.
|
Immediate postoperative (Tim), 6 weeks (T6w), 3 months (T3m), 6 months (T6m)
|
|
Graft area contraction
Időkeret: Immediate postoperative (Tim) to 6 months (T6m)
|
Percentage of graft area reduction between immediate postoperative and 6 months, assessed by 3D digital superimposition.
|
Immediate postoperative (Tim) to 6 months (T6m)
|
|
Change in graft volume
Időkeret: Immediate postoperative (Tim), 6 weeks (T6w), 3 months (T3m), 6 months (T6m)
|
Change in graft volume, measured in cubic millimeters (mm³), between immediate postoperative and 6 months, assessed by 3D digital superimposition.
|
Immediate postoperative (Tim), 6 weeks (T6w), 3 months (T3m), 6 months (T6m)
|
|
Vestibular depth
Időkeret: Baseline (T0) to 6 months (T6m)
|
Change in vestibular depth from baseline to 6 months, assessed both digitally and clinically.
|
Baseline (T0) to 6 months (T6m)
|
|
Surgical time
Időkeret: Intraoperative (Tim)
|
Time in minutes from anesthesia administration to placement of the last suture.
|
Intraoperative (Tim)
|
|
Adverse events
Időkeret: Immediate postoperative (Tim) to 6 months (T6m)
|
Incidence and nature of postoperative adverse events related to the free gingival graft procedure.
|
Immediate postoperative (Tim) to 6 months (T6m)
|
|
Clinician-perceived surgical difficulty
Időkeret: Intraoperative (Tim)
|
Degree of surgical difficulty perceived by the clinician at the end of the procedure, evaluated using a 100 mm visual analogue scale (0 = no difficulty, 100 = maximum imaginable difficulty).
|
Intraoperative (Tim)
|
|
Postoperative pain
Időkeret: Up to 7 days postoperat
|
Pain intensity recorded at the end of the procedure and at 2, 6, 12 and 24 hours, and daily for 7 days, using a 100 mm visual analogue scale (0 = no pain, 100 = worst imaginable pain).
|
Up to 7 days postoperat
|
|
Analgesic consumption
Időkeret: Up to 7 days postoperative
|
Number of doses of ibuprofen 600 mg and paracetamol 1 g consumed during the first 7 postoperative days.
|
Up to 7 days postoperative
|
|
Patient global satisfaction
Időkeret: 7 days postoperative
|
Overall satisfaction with the intervention evaluated at 7 days postoperative using a 100 mm visual analogue scale (0 = completely dissatisfied, 100 = completely satisfied).
|
7 days postoperative
|
|
Days with limitation of daily activity
Időkeret: Up to 7 days postoperative
|
Number of days with total or partial limitation of usual daily activity during the first 7 postoperative days.
|
Up to 7 days postoperative
|
Együttműködők és nyomozók
Szponzor
Együttműködők
Nyomozók
- Tanulmányi igazgató: Octavi Camps Font, University of Barcelona
Publikációk és hasznos linkek
Hasznos linkek
Tanulmányi rekorddátumok
Tanulmány főbb dátumok
Tanulmány kezdete (Becsült)
Elsődleges befejezés (Becsült)
A tanulmány befejezése (Becsült)
Tanulmányi regisztráció dátumai
Először benyújtva
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Első közzététel (Tényleges)
Tanulmányi rekordok frissítései
Utolsó frissítés közzétéve (Tényleges)
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Utolsó ellenőrzés
Több információ
A tanulmányhoz kapcsolódó kifejezések
Kulcsszavak
Egyéb vizsgálati azonosító számok
- 26/2026
Terv az egyéni résztvevői adatokhoz (IPD)
Tervezi megosztani az egyéni résztvevői adatokat (IPD)?
Gyógyszer- és eszközinformációk, tanulmányi dokumentumok
Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz
Egy amerikai FDA által szabályozott eszközterméket tanulmányoz
Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .